bioRxiv · 10.1101/2021.04.23.441101
Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees
Abstract
The drastic rise in the number of cases in Maharashtra, India has created a matter of concern for public health experts. Twelve isolates of VUI lineage B.1.617 were propagated in VeroCCL81 cells and characterized. Convalescent sera of the COVID-19 cases and recipients of BBV152 (Covaxin) were able to neutralize VUI B.1.617.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Yadav, P., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., Mohan, V. K.. 2021-04-23. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. https://doi.org/10.1101/2021.04.23.441101
Cite the original work for its findings. Save a collection to share your selection of sources.